Enginprime Medical Inc Announces First-in-Human Study of Its Leading OpusOne™ pVAD

---
Enginprime Medical Inc Announces First-in-Human Study of Its Leading OpusOne™ pVAD
Vote:
0 0
Previous Newmark Expands APAC Presence with Korea Launch, Appointing John Pritchard as Country Head
Next Newmark Expands APAC Presence with Korea Launch, Appointing John Pritchard as Country Head

Related News

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States

magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022

magAssist's NyokAssist™️ granted Designation by the FDA as a Breakthrough Device

MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE

Syntach AB announces partnership with Meditrial CRO to drive clinical development of groundbreaking Cardiac Support System

Pulnovo Medical Announces 3-Year Follow-up Results from PADN-5 at THT 2023, The Medical Device Maker Breaks New Ground in Heart Failure Treatment

menu
menu